DANORGANIC A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.4% 2.4% 2.4% 2.4% 2.4%  
Bankruptcy risk  5.5% 2.9% 3.0% 0.8% 1.2%  
Credit score (0-100)  43 58 56 92 81  
Credit rating  BBB BBB BBB AA A  
Credit limit (kDKK)  0.0 0.0 0.0 742.4 200.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Gross profit  3,798 5,899 5,885 5,753 4,246  
EBITDA  388 1,603 1,186 2,592 1,253  
EBIT  -530 548 209 1,806 898  
Pre-tax profit (PTP)  -543.4 492.0 195.5 1,784.2 839.7  
Net earnings  -425.5 403.7 159.2 1,391.8 654.6  
Pre-tax profit without non-rec. items  -543 492 195 1,784 840  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  3,889 2,931 2,185 1,456 1,203  
Shareholders equity total  3,075 3,479 3,638 5,030 5,684  
Interest-bearing liabilities  0.0 0.0 0.0 3.1 0.0  
Balance sheet total (assets)  11,403 16,532 11,816 10,324 11,405  

Net Debt  -399 -4,694 -1,696 -3,126 -648  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,798 5,899 5,885 5,753 4,246  
Gross profit growth  -36.6% 55.3% -0.2% -2.2% -26.2%  
Employees  9 9 9 6 6  
Employee growth %  0.0% 0.0% 0.0% -33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  11,403 16,532 11,816 10,324 11,405  
Balance sheet change%  1.5% 45.0% -28.5% -12.6% 10.5%  
Added value  387.7 1,603.3 1,186.1 2,783.4 1,253.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,835 -2,013 -1,723 -1,515 -609  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -14.0% 9.3% 3.6% 31.4% 21.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -4.6% 3.9% 1.5% 16.3% 8.3%  
ROI %  -8.2% 16.3% 5.9% 41.7% 16.8%  
ROE %  -8.0% 12.3% 4.5% 32.1% 12.2%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  27.0% 21.0% 30.8% 48.7% 49.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -103.0% -292.8% -143.0% -120.6% -51.7%  
Gearing %  0.0% 0.0% 0.0% 0.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 1,408.1% 3,885.3%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  0.8 1.0 1.0 1.4 1.6  
Current Ratio  0.9 1.0 1.2 1.7 1.8  
Cash and cash equivalent  399.2 4,693.8 1,695.7 3,129.2 648.4  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -717.1 587.8 1,438.1 3,558.9 4,466.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  43 178 132 464 209  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  43 178 132 432 209  
EBIT / employee  -59 61 23 301 150  
Net earnings / employee  -47 45 18 232 109